CoChat

Proton pump inhibitor therapy is a risk factor for Clostridium difficile ‐associated diarrhoea

YEARSLEY, K. A., GILBY, L. J., RAMADAS, A. V., KUBIAK, E. M., FONE, D. L., ALLISON, M. C. · 2006 · Alimentary Pharmacology & Therapeutics
Cited by 145

The DOI matches its Crossref record.

Abstract

Summary: Background: Inhibition of gastric acid removes a defence against ingested bacteria and spores, increasing the risk of some forms of gastroenteritis. Previous studies investigating a possible link between acid suppression therapy and Clostridium difficile ‐associated diarrhoea have reported conflicting results. Aim: To investigate whether acid suppression therapy is associated with an increased risk of C. difficile ‐associated diarrhoea. Methods: Prospective case–control study of 155 consecutive in‐patients with C. difficile ‐associated diarrhoea. Results: Antibiotics had been received by 143 (92%) of the C. difficile ‐associated diarrhoea group and 76 (50%) of the controls during the preceding 3 months. Among those receiving antibiotics, 59 (41%) of the C. difficile ‐associated diarrhoea group had also received acid suppression, compared with 21 (28%) of controls (OR 1.84, CI 1.01, 3.36, χ 2 = 4.0, P = 0.046). Among the entire C. difficile ‐associated diarrhoea group 64 (41%) had received acid suppression compared with 40 (26%) of controls (OR 1.99, CI 1.19, 3.31, χ 2 = 7.9, P = 0.005). Logistic regression analyses found that C. difficile ‐associated diarrhoea was independently associated with: antibiotic use (OR 13.1, 95% CI: 6.6, 26.1); acid suppression therapy (OR 1.90, 95% CI: 1.10, 3.29); and female sex (OR 1.79, 95% CI: 1.06, 3.04). Conclusions: The risk of C. difficile ‐associated diarrhoea in hospitalized patients receiving antibiotics may be compounded by exposure to proton pump inhibitor therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2036.2006.03015.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 145

Metadata

Authors
YEARSLEY, K. A., GILBY, L. J., RAMADAS, A. V., KUBIAK, E. M., FONE, D. L., & ALLISON, M. C.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2006-07-25
Volume
24
Issue
4
Pages
613-619
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W2071188969
Cited by
145
References
0
FWCI
8.41
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Proton pump inhibitor therapy is a risk factor for Clostridium difficile ‐associated diarrhoea. https://app.cochat.ai/papers/10.1111/j.1365-2036.2006.03015.x
The paper
YEARSLEY, K. A., GILBY, L. J., RAMADAS, A. V., KUBIAK, E. M., FONE, D. L., & ALLISON, M. C. (2006). Proton pump inhibitor therapy is a risk factor for Clostridium difficile ‐associated diarrhoea. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/j.1365-2036.2006.03015.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.